Tissue Regenix Group PLC (TRX.L)

TRX.L on London Stock Exchange

24.64GBp
4:54am EDT
Price Change (% chg)

0.00p (+0.00%)
Prev Close
24.50p
Open
24.50p
Day's High
--
Day's Low
--
Volume
5,846
Avg. Vol
102,107
52-wk High
33.00p
52-wk Low
11.25p

TRX.L

Chart for TRX.L

About

Tissue Regenix Group plc, is a United Kingdom-based holding company. It is a regenerative medical devices company, which uses animal or human tissue to replace damaged or worn out parts of the human body. The Principal activity of the Company is exploitation of platform technologies in the field of tissues engineering and... (more)

Overall

Beta: 0.75
Market Cap (Mil.): £160.26
Shares Outstanding (Mil.): 654.12
Dividend: --
Yield (%): --

Financials

  TRX.L Industry Sector
P/E (TTM): -- 139.94 33.54
EPS (TTM): -0.01 -- --
ROI: -25.75 -1.53 17.61
ROE: -25.75 -6.70 18.42
Search Stocks

BRIEF-Tissue Regenix shows results for Dermapure trial

* Initial clinical trial results from study into efficacy of Dermapure dermal allograft on acute wounds

17 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks